New Drugs in Hematology

1 New Drugs in Hematology Bologna, Royal Hotel Carlton, May 9-11, 2016 PROGRAM Monday, May 9, 2016 am Welcome and Introduction Three recent impressive stories Chairman: F. Pane am Brentuximab vedotin in lymphomas A. Younes am Blinatumumab in ALL Topp am CAR T-cells June am Coffee Break SESSION I: Classical Ph1-neg myeloproliferative neoplasms Chairmen: F. Passamonti, Vannucchi am Status of the art of treatment Mesa am Ruxolitinib in myelofibrosis F. Passamonti am Ruxolitinib in polycitemia vera Vannucchi am New JAK2 inhibitors in MPNs and combination therapy F.

2 Cervantes pm Interferons in MPNs Hasselbalch pm Newer Drugs for myelofibrosis G. Barosi pm LUNCH SESSION II: Hodgkin s lymphoma Chairmen: P. Borchman, Zinzani pm Status of the art of treatment P. Borchman pm Nivolumab A. Younes pm Pembrolizumab S. Schuster pm Bendamustine A. Moskowitz pm New Combo-steps A. Younes SESSION III: Chronic myeloid leukemia Chairmen: M. Gobbi, G. Rosti pm Status of the art of treatment M. Baccarani pm Nilotinib-based treatments and ABL001 G. Rosti pm Dasatinib and combination G.

3 Saglio pm Bosutinib Brummendorf pm Ponatinib G. Rosti Tuesday, May 10, 2016 Two transversal on lymphomas Drugs Chairman: P. Corradini am Bendamustine B. Cheson am - Lenalidomide T. Witzig SESSION IV: Non-Hodgkin s lymphoma (I) Chairmen: B. Cheson, A. Pinto am Status of the art of treatment B. Cheson am Obinutuzumab Sehn am Ublituximab N. Fowler am MOR208 Zinzani am anti-4-1BB A. Thall am Polatuzumab F. Morschhauser am Mogamulizumab M. Ogura am 177Lu-HH1 (Betalutin) A. Kolstad am CC-122 V. Ribrag am EDO-S101 O.

4 O Connor pm IMGN529 A. Stathis pm Selinexor S. Shacham pm Pixantrone R. Pettengell LUNCH SESSION V: Non-Hodgkin s lymphoma (II) Chairmen: U. Vitolo, M. Martelli pm Venetoclax S. Rule pm Idelalisib S. de Vos pm Ibrutinib M. Wang pm TGR-1202 O. O Connor pm Copanlisib M. Dreyling pm Duvelisib N. Fowler pm ACP-196 S. LeGouill pm Tazemetostat V. Ribrag SESSION VI: Chronic Lymphocitic Leukemia Chairmen: R. Fo , A. Cuneo pm Status of the art of management S. O Brien pm Ibrutinib Burger pm Idelalisib S.

5 Coutre pm Venetoclax P. Hillmen pm ACP-196 S. O Brien pm Duvelisib P. Porcu pm TGR-1202 and Ublituximab A. Mato Wednesday, May 11, 2016 Other two interesting issues Chairman: A. Genazzani, Zinzani am - Rituximab biosimilars Canonico, M. Peters am The role of liposomal doxorubicin in DLBCL lymphomas M. Spina SESSION VII: acute leukemia Chairmen: S. Amadori, G. Martinelli am Status of the art of treatment H. Dohner am Targeting BET in acute myeloid leukemia B. Huntly am IDH2 inhibitors in acute myeloid leukaemia E.

6 M. Stein am FLT3 inhibitors in acute myeloid leukaemia Stone am Inotuzumab ozogamicin in acute lymphoblastic leukaemia H. Kantarjian am BCR-ABL like in acute lymphoblastic leukaemia I. Iacobucci am The role of RO5503781 in acute myeloid leukaemia G. Martinelli SESSION VIII: Multiple myeloma Chairmen: M. Cavo, S. Lonial am Status of the art of treatment A. Palumbo am Modeling of disease evolution: what have we learned and how can we drive future treatment strategies? G. Morgan pm New insights into optimal use of PIs and IMiDs based on sensitizing targets and biomarkers P.

7 Moreau pm Histone deacetilase and kinase inhibitors S. Lonial pm Monoclonal antibodies and their integration into the modern therapeutic algorithms M. Cavo pm Immune checkpoint inhibitors and immune-based therapies P. Richardson pm Is personalized therapy ready for primetime? Kumar pm Conclusions and Arrivederci GENERAL INFORMATION MEETING VENUE Royal Hotel Carlton Via Montebello, 8 40121 Bologna, Italy Phone +39 051 249361 HOW TO GET THERE By car : From the motorway, turn into the ring road ("Tangenziale") - Exit 7 Fiera and follow direction city center and railway station.

8 By taxi: From the airport about 30 minutes. By bus: Bus 91 and Aerobus from the airport. By train: From the railway station walking distance. OFFICIAL LANGUAGE English. REGISTRATION FEE Euro 400,00 (Italian VAT included) The registration fee includes: Conference kit Participation in the scientific sessions Attendance Certificate Abstracts of the meeting Coffee breaks Lunches SLIDES Slides must be in English. Computer video projection will be available in Power Point. Other requirements should be communicated to the Organizing Secretariat as soon as possible.

9 Slides should be handed to the slide center one hour before the beginning of the session and collected at the end. BADGE All registered participants, speakers and exhibitors will be given a badge which they must wear to be admitted to the scientific sessions. ATTENDANCE CERTIFICATE A certificate will be given to all participants at the end of the Meeting. ITALIAN AND EUROPEAN CME Application to the Italian Ministry of Health and the European Board for Accreditation in Hematology (EBAH) will be submitted for physicians, biologists and chemists.

10 CHANGES Parts of the program may be changed if necessary.